Literature DB >> 7683589

Sera from patients with tuberculosis recognize the M2a-epitope (E2-subunit of pyruvate dehydrogenase) specific for primary biliary cirrhosis.

R Klein1, M Wiebel, S Engelhart, P A Berg.   

Abstract

Anti-M2 antibodies in primary biliary cirrhosis (PBC) have been shown to react with the alpha-ketoacid dehydrogenase complex of the inner mitochondrial membrane consisting of six epitopes (E2 subunit of the pyruvate dehydrogenase complex (PDC), 70 kD; protein X of the PDC, 56 kD; alpha-ketoglutarate dehydrogenase complex, 52 kD; branched-chain alpha-ketoacid dehydrogenase, 52 kD; E1 alpha subunit of PDC, 45 kD; and E1 beta-subunit of PDC, 36 kD). These epitopes are also present in the M2 fraction which is a chloroform extract from beef heart mitochondria. The E2 subunit of the PDC at 70 kD (M2a), especially, is a major target epitope which is recognized by about 85% of all PBC sera. However, analysing sera from 28 patients with active pulmonary tuberculosis it became evident that 12 (43%) also recognized the PDC-E2 subunit (M2a), as shown by Western blotting using the M2 fraction, the purified PDC, and the recombinant PDC-E2. In contrast, only two of 82 patients with other bacterial and viral infections including 25 patients with Escherichia coli infections reacted with the PBC-specific epitope at 70 kD. Naturally occurring mitochondrial antibodies (NOMA) were present in 54% of the patients with tuberculosis and in 50% of patients with other infectious disorders. They recognized either a determinant at 65 kD (epsilon) or at 60/55 kD (zeta/eta). None of the sera from 100 blood donors had anti-M2 but 14 had NOMA. Testing anti-M2 and NOMA-positive marker sera by Western blotting against membrane fractions derived from mycobacteria and E. coli it could be shown that--like mammalian mitochondria--they contain both the PBC-specific M2 antigen as well as the non-PBC-specific naturally occurring mitochondrial antigen system (NOMAg). The observation that PBC-specific antibodies were preferentially induced in patients suffering from a mycobacterial infection may provide some new clues to the still unknown etiology of PBC.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7683589      PMCID: PMC1554802          DOI: 10.1111/j.1365-2249.1993.tb03397.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

Review 1.  Nature of the mitochondrial antigens of primary biliary cirrhosis and their possible relationships to the etiology of the disease.

Authors:  H Baum
Journal:  Semin Liver Dis       Date:  1989-05       Impact factor: 6.115

Review 2.  Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis.

Authors:  A M Dannenberg
Journal:  Immunol Today       Date:  1991-07

Review 3.  Heat shock proteins and the immune response.

Authors:  S H Kaufmann
Journal:  Immunol Today       Date:  1990-04

Review 4.  Molecular definitions, autoepitopes, and enzymatic activities of the mitochondrial autoantigens of primary biliary cirrhosis.

Authors:  J Van de Water; C D Surh; P S Leung; S M Krams; D Fregeau; P Davis; R Coppel; I R Mackay; M E Gershwin
Journal:  Semin Liver Dis       Date:  1989-05       Impact factor: 6.115

5.  Mitochondrial M2 autoantigens and primary biliary cirrhosis.

Authors: 
Journal:  Lancet       Date:  1989-02-25       Impact factor: 79.321

6.  Demonstration of "naturally occurring mitochondrial antibodies" in family members of patients with primary biliary cirrhosis.

Authors:  R Klein; P A Berg
Journal:  Hepatology       Date:  1990-08       Impact factor: 17.425

7.  The E1 alpha and beta subunits of the pyruvate dehydrogenase complex are M2'd' and M2'e' autoantigens in primary biliary cirrhosis.

Authors:  S P Fussey; M F Bassendine; D Fittes; I B Turner; O F James; S J Yeaman
Journal:  Clin Sci (Lond)       Date:  1989-10       Impact factor: 6.124

Review 8.  Antimitochondrial antibodies in primary biliary cirrhosis and other disorders: definition and clinical relevance.

Authors:  P A Berg; R Klein
Journal:  Dig Dis       Date:  1992       Impact factor: 2.404

9.  Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction.

Authors:  S A Saboor; N M Johnson; J McFadden
Journal:  Lancet       Date:  1992-04-25       Impact factor: 79.321

10.  Autoantibodies in primary biliary cirrhosis: analysis of reactivity against eukaryotic and prokaryotic 2-oxo acid dehydrogenase complexes.

Authors:  S P Fussey; J G Lindsay; C Fuller; R N Perham; S Dale; O F James; M F Bassendine; S J Yeaman
Journal:  Hepatology       Date:  1991-03       Impact factor: 17.425

View more
  15 in total

1.  Identification of beta-subunit of bacterial RNA-polymerase--a non-species-specific bacterial protein--as target of antibodies in primary biliary cirrhosis.

Authors:  Kai-Wolfgang Roesler; Wolfgang Schmider; Manfred Kist; Stephen Batsford; Emile Schiltz; Mathias Oelke; Anja Tuczek; Therese Dettenborn; Dirk Behringer; Wolfgang Kreisel
Journal:  Dig Dis Sci       Date:  2003-03       Impact factor: 3.199

2.  Identification of new autoantigens for primary biliary cirrhosis using human proteome microarrays.

Authors:  Chao-Jun Hu; Guang Song; Wei Huang; Guo-Zhen Liu; Chui-Wen Deng; Hai-Pan Zeng; Li Wang; Feng-Chun Zhang; Xuan Zhang; Jun Seop Jeong; Seth Blackshaw; Li-Zhi Jiang; Heng Zhu; Lin Wu; Yong-Zhe Li
Journal:  Mol Cell Proteomics       Date:  2012-05-30       Impact factor: 5.911

Review 3.  Pathogenesis of primary biliary cirrhosis.

Authors:  David E J Jones
Journal:  Gut       Date:  2007-07-19       Impact factor: 23.059

4.  Primary biliary cirrhosis: epidemiology helping the clinician.

Authors:  J V Metcalf; D Howel; O F James; R Bhopal
Journal:  BMJ       Date:  1996-05-11

Review 5.  Primary biliary cirrhosis: what do autoantibodies tell us?

Authors:  Chao-Jun Hu; Feng-Chun Zhang; Yong-Zhe Li; Xuan Zhang
Journal:  World J Gastroenterol       Date:  2010-08-07       Impact factor: 5.742

6.  Ursodeoxycholic acid treatment lowers the serum level of antibodies against pyruvate dehydrogenase and influences their inhibitory capacity for the enzyme complex in patients with primary biliary cirrhosis.

Authors:  K E Kisand; A L Karvonen; M Vuoristo; M Färkkilä; J Lehtola; J Inkovaara; K V Kisand; T Miettinen; K Krohn; R Uibo
Journal:  J Mol Med (Berl)       Date:  1996-05       Impact factor: 4.599

Review 7.  The immunology of primary biliary cirrhosis: the end of the beginning?

Authors:  J M Palmer; J A Kirby; D E J Jones
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

8.  Apoptosis as a mechanism for cell surface expression of the autoantigen pyruvate dehydrogenase complex.

Authors:  P Macdonald; J Palmer; J A Kirby; D E J Jones
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

Review 9.  Role for mycobacterial infection in pathogenesis of primary biliary cirrhosis?

Authors:  Daniel Smyk; Eirini I Rigopoulou; Yoh Zen; Robin Daniel Abeles; Charalambos Billinis; Albert Pares; Dimitrios P Bogdanos
Journal:  World J Gastroenterol       Date:  2012-09-21       Impact factor: 5.742

Review 10.  Autoimmune liver serology: current diagnostic and clinical challenges.

Authors:  Dimitrios-P Bogdanos; Pietro Invernizzi; Ian-R Mackay; Diego Vergani
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.